	US 12,228,579 B2
	Methods of prognosis and treatment
Eran Eden, Haifa (IL); Kfir Oved, Hof HaCarmel (IL); Assaf Cohen-Dotan, Natania (IL); Roy Navon, Tel-Aviv (IL); Olga Boico, Atlit (IL); and Meital Paz, Haifa (IL)
Assigned to MeMed Diagnostics Ltd., Tirat HaCarmel (IL)
Filed by MeMed Diagnostics Ltd., Tirat HaCarmel (IL)
Filed on Jun. 16, 2022, as Appl. No. 17/841,704.
Application 17/841,704 is a division of application No. 16/334,033, granted, now 11,385,241, previously published as PCT/IL2017/051088, filed on Sep. 27, 2017.
Claims priority of provisional application 62/401,296, filed on Sep. 29, 2016.
Prior Publication US 2022/0326256 A1, Oct. 13, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. G01N 33/50 (2006.01); G01N 33/52 (2006.01); G01N 33/53 (2006.01); G01N 33/58 (2006.01); G01N 33/60 (2006.01); G01N 33/68 (2006.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01); C07K 14/47 (2006.01); C07K 14/52 (2006.01); C07K 14/525 (2006.01); C07K 14/54 (2006.01)

CPC G01N 33/6893 (2013.01) [G01N 33/50 (2013.01); G01N 33/52 (2013.01); G01N 33/53 (2013.01); G01N 33/582 (2013.01); G01N 33/60 (2013.01); G01N 33/6863 (2013.01); G01N 33/6869 (2013.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01); C07K 14/4716 (2013.01); C07K 14/4737 (2013.01); C07K 14/522 (2013.01); C07K 14/525 (2013.01); C07K 14/5412 (2013.01); G01N 2333/52 (2013.01); G01N 2333/525 (2013.01); G01N 2333/5412 (2013.01); G01N 2800/26 (2013.01)]

8 Claims

1. A method for triaging subjects who are suspected of having a viral infection, comprising measuring the TRAIL protein level in a blood sample of the subject, wherein when the TRAIL level is below 30 pg/ml, the subject is subjected to a management selected from the group consisting of hospitalization, mechanical ventilation, invasive monitoring, sedation, intensive care admission and surgical intervention.